Metraipolis › archive › dc_6ac738201fa1

Overlapping Toxicities of Pembrolizumab and Lenvatinib: A Case of Capillary Leak Syndrome with Severe Erythroblastosis — Europe PMC PMID:42187585

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42187585
DOI
10.3390/curroncol33050268
License (as archived)
solo-consultazione
Archived
2026-11-02T17:24:18.594Z
SHA-256 of the archived text
32291f0e26d444249eee8eb3a34030502299e4e8a9392c34d39c056220d7ca1b
Stable URL of this page
https://metraipolis.com/documento/dc_6ac738201fa1

How to cite

Overlapping Toxicities of Pembrolizumab and Lenvatinib: A Case of Capillary Leak Syndrome with Severe Erythroblastosis — Europe PMC PMID:42187585 — Europe PMC (en), https://europepmc.org/article/MED/42187585 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ac738201fa1 (Metraipolis archive dc_6ac738201fa1, sha256 32291f0e26d444249eee8eb3a34030502299e4e8a9392c34d39c056220d7ca1b)
BibTeX
@misc{dc6ac738201fa1,
  title = {Overlapping Toxicities of Pembrolizumab and Lenvatinib: A Case of Capillary Leak Syndrome with Severe Erythroblastosis — Europe PMC PMID:42187585},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42187585},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ac738201fa1; sha256 32291f0e26d444249eee8eb3a34030502299e4e8a9392c34d39c056220d7ca1b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42187585. Agents can read the archived copy with the MCP tool read_document.